Monoarylhydrazones of α-lapachone: Synthesis, chemical properties and antineoplastic activity

Pharmazie

Volumn 58, Issue 10, 2003, Pages 690-695

  Renou, Sergio Gastón ^a   Asis S E ^a   Abasolo, M I ^a   Bekerman, D G ^a   Bruno, A M ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA LAPACHONE HYDRAZONE; BETA LAPACHONE; HYDRAZINE DERIVATIVE; HYDRAZONE DERIVATIVE; LAPACHOL; NAPHTHOQUINONE; NITROGEN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CHEMICAL STRUCTURE; CYCLIZATION; CYTOTOXICITY; DNA BINDING; HUMAN; HUMAN CELL; OXIDATION REDUCTION REACTION; QUANTITATIVE STRUCTURE ACTIVITY RELATION; SYNTHESIS; TABEBUIA; TUMOR CELL LINE;

ALGORITHMS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CHEMISTRY, PHYSICAL; DNA; DRUG SCREENING ASSAYS, ANTITUMOR; ELECTROCHEMISTRY; HUMANS; HYDRAZONES; MODELS, MOLECULAR; NAPHTHOQUINONES; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0142229427     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Patai, A.: The chemistry of the quinoidal compounds, p, 347. John Wiley & Sons, London 1974
2. Lagrota, M.; Wigg, M.; Aguiar, A. et al.: Rev. Latinoam. Microbiol. 28, 221 (1986)
3. Carvalho, L.; Rocha, E.; Raslan, D. et al.: Braz. J. Med. Biol. Res. 21, 485 (1988)
4. Guiraud, P.; Steiman, R.; Campos-Takaki, G. et al.: Planta Med. 60, 373 (1994)
5. Gafner, S.; Wolfender, J.; Nianga, M. et al.: Phytochemistry 42, 1315 (1996)
6. Li, C.; Zhang L.; Dezube, B. et al.: Proc. Natl. Acad. Sci. 90, 1839 (1993)
7. Lima, O.; D'Albuquerque, I.; Lima, C. et al.: Rev. Inst, Antib. Univ. Recife 4, 3 (1962)
8. Fujiwara, A.; Mori, T.; Lida, A. et al.: J. Natl. Prod. 61, 629 (1998)
9. Boothman, D.; Pardee, A.: Proc. Natl. Acad. Sci. 86, 4963 (1989)
10. Dolan, M.; Frydman, B.; Thompson, C. et al.: Anticancer Drugs 9, 437 (1998)
11. Schürch, A.; Wehrli, W.: Eur. J. Biochem. 84, 197 (1978)
12. Boothman, D.; Greer, S.; Pardee, A.: Cancer Res. 47, 5361 (1987)
13. Li, C.; Wang, C.; Pardee, A.: Cancer Res. 55, 3712 (1995)
14. Planchon, S.; Wuerzberger-Davis, S.; Pink, J.: Oncol, Rep. 6, 485 (1999)
15. Manna, S.; Gad, Y.; Mukhopadhyay, A.: Biochem. Pharmacol. 57, 763 (1999).
16. Chau, Y.; Shiah, S.; Don, M.: Free Radic. Biol. Med. 24, 660 (1998)
17. Li, C.; Averboukh, L.; Pardee, A.: J. Biol. Chem. 268, 22463 (1993)
18. Weller, M.; Winter, S.; Schmidt, C.: Int. J. Cancer 73, 707 (1997)
19. Pinto, M.; Pinto, A.; Oliveira, C.: An. Acad. Brasi. Cien. 52, 481 (1980)
20. Pinto, A.; Pinto, M.; Oliveira, C.: An. Acad. Brasi. Cien. 54, 107 (1982)
21. Pinto, A.; Ferreira, V.; Pinto, M.: Synthetic Comm. 15, 1181 (1985)
22. Chavez, J.; Pinto, M.; Pinto, A.: Braz. Chem. Soc. 1, 21 (1990)
23. Benedetti-Doctorovich, V.; Burgess, E.; Lambropolus, J.; Lednicer, D.; Van Derveer, D.; Zalkow, L.: J. Med. Chem. 37, 710 (1994)
24. Di Chenna, P.; Benedetti-Doctorovich, V.; Baggio, R.; Garland, M.; Burton, G.: J. Med, Chem, 44, 2486 (2001)
25. HyperChem® Release 7 for Windows® Copyright 2002 Hypercube, Inc
26. Bullock, M.; Hand, J.: J. Am. Chem. Soc. 78, 5854 (1956)
27. Asís, S.; Bruno, A.; Martínez A.; Sevilla M.; Gaozza, C. et al.: Il Farmaco 54, 517 (1999)
28. Boyd, M.: Principles and Practice of Oncology 3, 1 (1989).
29. Hansch, C.; Leo, A.; Unger, S.; Kim, K.; Nikaitani, D.; Lien, E.: J. Med. Chem. 16, 1207 (1973)
30. Kubinyi, H.: QSAR: Hansch Analysis and Related Approaches. Vol. 1, p. 25, VCH, New York 1993
31. ChemSketch® 2.0 Advanced Chemistry Development Inc. Copyright® 1994-1996
32. Schulz, W.; Islam, I.; Skibo, E.: J. Med. Chem. 38, 109 (1995).
33. Cruz, F.; Docampo, R.; De Souza, W.: Acta Trop. 35, 35 (1978).
34. Frydman, B.; Martin, L.; Sun, J.; Neder, K. et al.: Cancer Res. 57, 620 (1997)
35. Oliveira-Brett, A.; Goulart, M.; Abreu, F.: Bioelectrochemistry 56, 53 (2002)
36. Beilsteins Handbuch der Organische Chemie 8, 326. Verlag Von Julius Springer, Berlin 1937
37. Dictionary of Organic Compounds, Vol. 4, p. 4066, Sixth Ed. Chapman & Hall, London 1996